Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms

Neuroblastoma, Ganglioneuroblastoma

Glioblastoma

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Brain Neoplasms

Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Urothelial Carcinoma

Glioblastoma

Brain Neoplasms, Craniopharyngioma

Muscle-invasive Urothelial Cancer of the Bladder

Squamous Cell Carcinoma of Head and Neck

Estrogen Receptor Positive Breast Cancer

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Neoplasms

Astrocytoma, Ependymoma, Glioblastoma

Urinary Bladder Neoplasms, Prostatic Hyperplasia

Urothelial Carcinoma of the Bladder

Urinary Bladder Neoplasms

Pathologic Complete Response, Neoplasms, Sarcoma

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Brain Neoplasms, Glioma

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Paranasal Sinus Neoplasms

Clinical Trials

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

GAIN-BCG

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

Niraparib/TTFields in GBM

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer

Tn-Miner

NEO-BLAST

TEMPO-MIBC

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

SarQuantIRM

CBPTMI

Validation of VI-RADS for the Detection of Detrusor Muscle Invasion

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Quantitative Imaging Biomarkers for Sarcoma

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

NEOPA

Chemoradiation in Locally Advanced Pancreatic Cancer

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer